Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

An elderly woman's swollen, painful foot was found to be caused by a rare type of bone lymphoma, which improved with radiation treatment.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

BTNL2 helps protect hair follicles from immune attacks.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

TGF-β is found in hair follicles and may cause hair loss in alopecia areata.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Baricitinib was effective in treating both early and late onset alopecia areata.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Early immunosuppressive therapy leads to favorable outcomes in Filipino lupus patients with myocarditis.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

JAK inhibitors may help treat alopecia areata by reversing hair loss.